Journal article
Pemetrexed safety and dosing strategy.
Abstract
Pemetrexed is a novel antifolate/antimetabolite that inhibits several folate-dependent enzymes, including thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide transformylase. As a class, antifolates have been associated with sporadic severe myelosuppression with gastrointestinal toxicity. Although infrequent, a combination of such toxicities carries a high risk of potentially life-threatening complications. Severe …
Authors
Niyikiza C; Hanauske A-R; Rusthoven JJ; Calvert AH; Allen R; Paoletti P; Bunn PA
Journal
Seminars in Oncology, Vol. 29, No. 6 Suppl 18, pp. 24–29
Publisher
Elsevier
Publication Date
December 2002
DOI
10.1053/sonc.2002.37465
ISSN
0093-7754